Prenetics Global LTD

Form 4F-120-F13G

Insider Trading (Form 4)

See all →
NASDAQ
PRE
Prenetics Global LTD
Form 4: Prenetics Global Director Reports Stock Transaction
Hudson Blake Leogrande, a Director of Prenetics Global Ltd, reported multiple transactions in common stock on October 4, 2026.
NASDAQ
PRE
Prenetics Global LTD
Form 4: Prenetics Global CFO Reports Stock Transaction
Hoi Chun Lo, Chief Financial Officer of Prenetics Global Ltd, reported multiple transactions in common stock on September 30, 2026.
NASDAQ
PRE
Prenetics Global LTD
Form 4: Prenetics Global Director Reports Stock Transaction
Hudson Blake Leogrande, a Director of Prenetics Global Ltd, reported multiple transactions in common stock on September 4, 2026.
NASDAQ
PRE
Prenetics Global LTD
Form 4: Prenetics Global Executive Receives Stock Grant
Thuan Yen Tat, VP, Finance of IM8 (US) LLC of Prenetics Global Ltd, received 10,730 shares of common stock on September 3, 2026.
NASDAQ
PRE
Prenetics Global LTD
Form 4: Prenetics Global CFO Buys Shares
Brian J Rosin, CFO of IM8 (US) LLC of Prenetics Global Ltd, purchased 23,100 shares of common stock on August 24, 2026.
NASDAQ
PRE
Prenetics Global LTD
Form 4: Prenetics Global CFO Reports Stock Transaction
Hoi Chun Lo, Chief Financial Officer of Prenetics Global Ltd, reported multiple transactions in common stock on August 21, 2026.

Schedule 13G - Passive Investments

NASDAQ
PRE
Prenetics Global LTD
SCHEDULE: Prenetics Global Ltd: Stakeholder Ownership Update
Genetel Bioventures Limited and Michael Yang Mengsu report beneficial ownership of 3.3% of Prenetics Global Ltd's Class A Ordinary Shares as of March 31, 2026.